## 2026-09-21T19:25:25Z
You are Worker M3: Educational Core & Clinical Context Pages Builder.
Your assigned working directory is:
`C:\Users\imgk3\teamwork_projects\colonoscopy_ai_guide\.agents\worker_m3`

Project working directory:
`C:\Users\imgk3\teamwork_projects\colonoscopy_ai_guide`

MANDATORY INTEGRITY WARNING:
DO NOT CHEAT. All implementations must be genuine. DO NOT hardcode test results, create dummy/facade implementations, or circumvent the intended task. A Forensic Auditor will independently verify your work. Integrity violations WILL be detected and your work WILL be rejected.

Primary Sources:
1. `C:\Users\imgk3\teamwork_projects\colonoscopy_ai_guide\.agents\orchestrator\synthesis_m1.md`
2. `C:\Users\imgk3\teamwork_projects\colonoscopy_ai_guide\.agents\explorer_m1_1\clinical_ledger.md` (79.8 KB of verified clinical data)
3. `C:\Users\imgk3\teamwork_projects\colonoscopy_ai_guide\.agents\explorer_m1_3\integrity_chakra_ledger.md`
4. Design System & Assets: `assets/css/main.css` and `assets/js/main.js`

Your Task:
Build five production-ready, beautifully styled, deeply detailed HTML pages:
1. `index.html` (Landing Page):
   - Hero section with glowing space backdrop, title "Colonoscopy AI & ChakraModel Research Platform", subtitle explaining dual mission (empowering patients & equipping AI researchers).
   - Dual Audience Paths:
     - Public & Patients path: "Understand Your Procedure & How AI Protects You" (links to 01, 02, 06b, 12).
     - Researchers & Engineers path: "Explore Architectures, Benchmarks & Dataset Flaws" (links to 03, 04, 05, 06, 08, 09, 10).
   - Mission statement & Key Statistics counters:
     - 41 Randomized Controlled Trials (31,789 patients)
     - 55% reduction in Adenoma Miss Rate (AMR)
     - 1.0% increase in ADR = 3% decrease in CRC incidence (Corley et al., NEJM)
     - <40 ms real-time clinical inference latency
     - 6 commercial FDA/CE approved systems
     - 4,275 false-alarm negative frames benchmarked
   - Quick Navigation Grid linking to all 12 subpages.
   - Intro to ChakraModel project and benchmark integrity discovery.
   - Sticky navigation, scroll progress bar, dark/light toggle, and footer.

2. `pages/01-what-is-colonoscopy.html` (Anatomy, Procedure & Screening):
   - Colorectal anatomy interactive overview: 8 zones (Cecum, Ascending, Hepatic Flexure, Transverse, Splenic Flexure, Descending, Sigmoid, Rectum) and clinical inspection significance.
   - Bowel preparation protocols: diet, split-dose PEG, Boston Bowel Preparation Scale (BBPS 0-9) criteria.
   - Procedure workflow: Cecal intubation (CIR target >=95%), mucosal withdrawal inspection (minimum 6 minutes, optimal 8-9 minutes).
   - Core quality metrics: Adenoma Detection Rate (ADR), Polyp Detection Rate (PDR), difference between ADR and PDR, Adenoma Miss Rate (AMR: 20-26% standard, up to 35% for flat/diminutive polyps).
   - Why AI Matters: Human fatigue, subtle flat polyps, reducing interval colorectal cancers.
   - Wrap technical terms in `<span class="glossary-term" data-term="...">term</span>` for tooltips.

3. `pages/02-polyp-types.html` (Morphology, Histology & Risk Stratification):
   - Paris Classification of Superficial Neoplastic Lesions:
     - Type 0-I (Polypoid): 0-Ip (pedunculated), 0-Is (sessile).
     - Type 0-II (Non-polypoid): 0-IIa (slightly elevated), 0-IIb (flat), 0-IIc (slightly depressed).
     - Type 0-III (Excavated/ulcerated).
     - Laterally Spreading Tumors (LST-G granular, LST-NG non-granular).
   - Size Stratification & Malignancy Risk: Diminutive (<=5 mm), Small (6-9 mm), Large (>=10 mm).
   - Histological Pathways:
     - Conventional Adenoma-Carcinoma Sequence: Tubular, Tubulovillous, Villous adenoma (APC, KRAS, TP53).
     - Serrated Pathway: Hyperplastic polyps, Sessile Serrated Lesions (SSL/SSA, dangerous flat mucus-capped proximal polyps, BRAF, CIMP, MSI-H), Traditional Serrated Adenomas (TSA).
   - Optical Classification Standards: Kudo Pit Pattern (I to V), NICE Classification (Types 1-3), JNET Classification (Types 1, 2A, 2B, 3).
   - Wrap technical terms in `<span class="glossary-term" data-term="...">term</span>`.

4. `pages/06b-clinical-evidence.html` (Clinical Trials & Real-World Evidence):
   - Randomized Controlled Trials (RCT) landscape: 41 RCTs, 31,789 patients.
   - Landmark RCT Deep Dives:
     - Wang et al. (Lancet Oncology 2019, Gastrointestinal Endoscopy 2020) landmark Chinese RCTs.
     - Repici et al. (Annals of Internal Medicine 2020) European multi-center RCT.
     - Wallace et al., Mori et al., Hassan et al.
   - The Clinical Paradox & AGA 2025 Model:
     - ADR increases by ~20% relative (RR 1.20), AMR drops by 55% (RR 0.45).
     - Critical nuance: Gains concentrate in diminutive polyps (<=5 mm); advanced adenoma detection shows no significant increase (RR 1.01).
     - Trade-offs: 11% increase in non-neoplastic resections (28.8% to 34.0%), 6-35 extra surveillance colonoscopies per 10k patients.
   - Cognitive Deskilling: Budzyń et al. (Lancet Gastroenterology & Hepatology, Aug 2025) ACCEPT trial showing -6.0% absolute ADR drop when endoscopists perform standard colonoscopy after CADe exposure.
   - ASGE PVI criteria (>=90% NPV for CADx "diagnose and leave") and guideline stances (AGA, ESGE, BMJ/MAGIC, WEO).
   - Wrap technical terms in `<span class="glossary-term" data-term="...">term</span>`.

5. `pages/07-clinical-systems.html` (Commercial CADe/CADx Systems):
   - Commercial AI Systems Comprehensive Profiles:
     - Medtronic GI Genius (Cosmo / Medtronic, FDA De Novo granted 2021, CE mark, dedicated inline hardware, latency <40ms, RCT backing).
     - Fujifilm CAD EYE (multi-light BLI/LCI, simultaneous CADe detection and CADx characterization, CE mark, PMDA).
     - Olympus ENDO-AID (Odin Vision / Olympus, EVIS X1 platform, CE mark, real-time bounding box).
     - NEC WISE VISION (CE mark, PMDA, ultra-fast FPGA/GPU processing, visual & audio alert).
     - Pentax Medical Discovery (i-scan optical enhancement, CE mark).
     - MAGENTIQ-COLO (FDA 510(k) cleared 2023, CE mark, US multi-center trial).
   - Comparison Matrix Table: Manufacturer, Regulatory clearance (FDA / CE / PMDA), CADe vs CADx, Endoscopic platform compatibility, Latency / Frame rate, Trial evidence.
   - Hardware implementation reality: Inline video appliances, HDMI/SDI pass-through, strict latency budget (<40ms) to avoid endoscopist visual disorientation during scope manipulation.

Strict Requirements:
- Use consistent navigation header with `#scroll-progress`, links to all pages, dark/light toggle button, and mobile drawer.
- Use `assets/css/main.css` and `assets/js/main.js`.
- Write your completion report to `C:\Users\imgk3\teamwork_projects\colonoscopy_ai_guide\.agents\worker_m3\handoff.md`.
